TRT vs Tirzepatide

About this video

Gillett and O’Hara dissect a study and media coverage claiming tirzepatide raised testosterone and improved erectile function more than testosterone replacement in men with very low testosterone. They argue the comparison is flawed because, in their reading, the testosterone arm was not adjusted according to the protocol the study said it followed, leaving that group still below the usual reference range. They agree tirzepatide can raise testosterone indirectly by improving metabolic health, insulin and binding-protein dynamics, and note lifestyle alone helped in the study. Their conclusion is deliberately non-binary: Gillett presents metabolic treatment and testosterone replacement as different tools that can be combined after shared decision-making about risks.

Key takeaways

• Check whether a comparator arm was actually dosed to its own protocol before trusting a headline
• Improving metabolic health can raise endogenous testosterone, the hosts argue
• Testosterone replacement is not presented as a reliable weight-loss treatment on its own
• Low testosterone and metabolic disease can be treated together rather than as an either-or choice
• Study claims amplified by media and AI summaries deserve extra scepticism

Episode details: published August 22, 2025 · 1.7K views · 11:29 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.

← Previous: We Answer Your Most Asked Questions | Ft. David Demesquita · Next: Shoulder Pain: Is surgery always the answer? →

All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)